Arginase inhibition enhances angiogenesis in endothelial cells exposed to hypoxia

Microvasc Res. 2015 Mar:98:1-8. doi: 10.1016/j.mvr.2014.11.002. Epub 2014 Nov 7.

Abstract

Hypoxia-induced arginase elevation plays an essential role in several vascular diseases but influence of arginase on hypoxia-mediated angiogenesis is completely unknown. In this study, in vitro network formation in bovine aortic endothelial cells (BAEC) was examined after exposure to hypoxia for 24h with or without arginase inhibition. Arginase activity, protein levels of the two arginase isoforms, eNOS, and VEGF as well as production of NO and ROS were examined to determine the involvement of arginase in hypoxia-mediated angiogenesis. Hypoxia elevated arginase activity and arginase 2 expression but reduced active p-eNOS(Ser1177) and NO levels in BAEC. In addition, both VEGF protein levels and endothelial elongation and network formation were reduced with continued hypoxia, whereas ROS levels increased and NO levels decreased. Arginase inhibition limited ROS, restored NO formation and VEGF expression, and prevented the reduction of angiogenesis. These results suggest a fundamental role of arginase activity in regulating angiogenic function.

Keywords: Angiogenesis; Arginase; Endothelial cell; Endothelial nitric oxide synthase (eNOS); Reactive oxygen species (ROS).

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Aorta / cytology
  • Aorta / enzymology
  • Arginase / antagonists & inhibitors
  • Arginase / metabolism*
  • Cattle
  • Cell Hypoxia
  • Endothelial Cells / enzymology*
  • Endothelium, Vascular / enzymology
  • Hypoxia / pathology*
  • Neovascularization, Pathologic*
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type III / metabolism
  • Reactive Oxygen Species / metabolism
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Reactive Oxygen Species
  • Vascular Endothelial Growth Factor A
  • Nitric Oxide
  • Nitric Oxide Synthase Type III
  • Arginase